As part of the emergency approval, Pfizer needs to continue providing information to the health ministry on the safety, efficacy and quality of the vaccine in the concerned age group, BBC reported.
All those above the age of 16 were already eligible for the Pfizer jab in Canada.
Last March, Pfizer had said initial results from vaccine trials in this age group showed 100 percent efficacy and produced a strong immune response.
The aim of vaccinating adolescents would be in order to continue physical schooling, reduce the spread of COVID-10 in the community at large and protect children with comorbidities.
“Today’s expansion of our authorisation represents a significant step forward in helping the Canadian government broaden its vaccination program and begin to help protect adolescents before the start of the next school year,” Fabien Paquette, vaccines lead for Pfizer Canada, said in a statement.
Besides Pfizer, vaccine manufacturer Moderna and Johnson & Johnson are also currently…
